^
Association details:
| Biomarker: | No biomarker |
|---|---|
| Cancer: | Hodgkin Lymphoma |
| Regimen: | DHAP (cisplatin + cytarabine + dexamethasone injection) |
| Direction: | Sensitive |
Evidence:
Source:
Excerpt:
Hodgkin Lymphoma: CHL, Second-line option added:...DHAP (dexamethasone, cisplatin, high-dose cytarabine).
